Correlation Between Tanvex BioPharma and Intech Biopharm
Can any of the company-specific risk be diversified away by investing in both Tanvex BioPharma and Intech Biopharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tanvex BioPharma and Intech Biopharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tanvex BioPharma and Intech Biopharm, you can compare the effects of market volatilities on Tanvex BioPharma and Intech Biopharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tanvex BioPharma with a short position of Intech Biopharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tanvex BioPharma and Intech Biopharm.
Diversification Opportunities for Tanvex BioPharma and Intech Biopharm
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Tanvex and Intech is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Tanvex BioPharma and Intech Biopharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intech Biopharm and Tanvex BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tanvex BioPharma are associated (or correlated) with Intech Biopharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intech Biopharm has no effect on the direction of Tanvex BioPharma i.e., Tanvex BioPharma and Intech Biopharm go up and down completely randomly.
Pair Corralation between Tanvex BioPharma and Intech Biopharm
Assuming the 90 days trading horizon Tanvex BioPharma is expected to generate 2.35 times more return on investment than Intech Biopharm. However, Tanvex BioPharma is 2.35 times more volatile than Intech Biopharm. It trades about -0.01 of its potential returns per unit of risk. Intech Biopharm is currently generating about -0.19 per unit of risk. If you would invest 6,940 in Tanvex BioPharma on August 30, 2024 and sell it today you would lose (180.00) from holding Tanvex BioPharma or give up 2.59% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Tanvex BioPharma vs. Intech Biopharm
Performance |
Timeline |
Tanvex BioPharma |
Intech Biopharm |
Tanvex BioPharma and Intech Biopharm Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tanvex BioPharma and Intech Biopharm
The main advantage of trading using opposite Tanvex BioPharma and Intech Biopharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tanvex BioPharma position performs unexpectedly, Intech Biopharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intech Biopharm will offset losses from the drop in Intech Biopharm's long position.Tanvex BioPharma vs. Medigen Vaccine Biologics | Tanvex BioPharma vs. OBI Pharma | Tanvex BioPharma vs. TaiMed Biologics | Tanvex BioPharma vs. Adimmune Corp |
Intech Biopharm vs. Unitech Computer Co | Intech Biopharm vs. Professional Computer Technology | Intech Biopharm vs. Cameo Communications | Intech Biopharm vs. HIM International Music |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world |